Abstract: A coilbox is provided for winding a metal strip to form a coil and for unwinding the metal strip from the coil. In order to further develop a known coilbox in such a manner that the position of the coil is known at all times, in particular during its passive transfer from the winding station to the unwinding station, at least one additional roller rotatably mounted on the frame is provided.

Abstract: The invention relates to a roll stand (1) as a constituent part of a roll stand group (2) in a high-speed wire mill, having at least one roll pair or roll ring pair (5) and a drive shaft (7) which is connected to a motor (6), characterized in that each roll stand (1) of this roll stand group (2) is assigned a motor (6) and a drive shaft (7), and the motor (6), the drive shaft (7) and the at least one roll pair or roll ring pair (5) are arranged linearly with respect to one another.

Abstract: The present invention relates to a transdermal therapeutic system for applying the active ingredient norelgestromin onto the skin, optionally in combination with estrogens. It further relates to the use of such systems for hormonal contraception, and for hormone replacement therapy.

Abstract: The present invention relates to a transdermal therapeutic system for applying the active ingredient norelgestromin onto the skin, optionally in combination with estrogens. It further relates to the use of such systems for hormonal contraception, and for hormone replacement therapy.

Abstract: The present invention relates to a method of dynamically supplying coolant to a cooling device, in particular at least one spray bar, for cooling metal strip or other rolled stock. According to the method, a pre-accelerated stream of coolant is provided, which passes by the cooling device (1) and is fed into a return (3). Furthermore, the presence and/or the temperature of a metal strip or other rolled stock to be cooled is monitored and, dependent on the presence and/or the temperature of the metal strip or the other rolled stock, the stream of coolant is diverted to the cooling device (1), wherein, instead of passing by the cooling device (1) and being fed into a return (3), the stream of coolant is fed to the cooling device (1) for cooling the metal strip or the other rolled stock. The present invention also comprises a corresponding device for carrying out the method.

Abstract: The present invention relates to a transdermal therapeutic system for applying the active ingredient norelgestromin onto the skin, optionally in combination with estrogens. It further relates to the use of such systems for hormonal contraception, and for hormone replacement therapy.

Abstract: The transdermal pharmaceutical preparations for the treatment of Parkinson's disease contain a combination of at least two active substances selected from the following groups of active substances: dopamine agonists and L-dopa, monoamine oxidase inhibitors, anticholinergics, NMDA-receptor antagonists, sympathomimetics; at least two of the said active substances being members of different active substance groups.

Abstract: The present invention relates to Transdermal Therapeutic Systems having a silicone adhesive layer, to Transdermal Therapeutic Systems providing specific plasma concentrations, to their manufacture and use.

Abstract: This invention relates to a transdermal therapeutic system (TTS) releasing an active pramipexol agent during a time ranging from 4 to 7 days.

Abstract: The invention relates to a roll stand (1) as a constituent part of a roll stand group (2) in a high-speed wire mill, having at least one roll pair or roll ring pair (5) and a drive shaft (7) which is connected to a motor (6), characterized in that each roll stand (1) of this roll stand group (2) is assigned a motor (6) and a drive shaft (7), and the motor (6), the drive shaft (7) and the at least one roll pair or roll ring pair (5) are arranged linearly with respect to one another.

Abstract: The present invention relates to a quickly decomposing oral drug preparation, for the application of active ingredient combinations for smoking withdrawal, which contains nicotine, a nicotine salt, a nicotine derivative, or a substance that reacts to nicotine, in combination with another active ingredient, and the use of such a drug preparation for the treatment of smoking withdrawal, and the use of nicotine, and/or nicotine salts or derivatives, for the production of medications for the treatment of smoking withdrawal. The active ingredient that is to be administered, in combination, for this purpose is a centrally active ingredient, preferably an antidepressant for the fighting of psychic dependency in terms of a smoking withdrawal therapy. The administration of the active ingredient combination to the patient should be handled in a simple and reliable way and should exclude side effects to a large extent.

Abstract: The present invention relates to a transdermal therapeutic system for applying the active ingredient norelgestromin onto the skin, optionally in combination with estrogens. It further relates to the use of such systems for hormonal contraception, and for hormone replacement therapy.

Abstract: Sheet-like dosage forms that quickly dissolve or disintegrate in an aqueous environment, for the application of active agent combinations for the treatment of hypertension. The dosage forms contain at least two active agents that are suitable for the treatment of hypertension. The antihypertensive agents are selected from the group that encompasses beta receptor blockers, alpha receptor blockers, calcium antagonists, ACE inhibitors, AT1 antagonists, centrally acting antihypertensive agents, direct vasodilators, and diuretics. The use of active agent combinations according to the invention for the production of an oral dosage form for the treatment of high blood pressure, a method for the therapeutic treatment of hypertension, and a method for the production of a sheet-like dosage form are also disclosed.

Abstract: Sheet-like dosage forms for pain therapy, based on hydrophilic polymers, which rapidly dissolve or disintegrate in an aqueous environment and which release active agent combinations when placed into a body orifice or body cavity, and which are preferably orally administrable, with the dosage form containing an active agent combination consisting of an opioid and a second substance The second active agent is a non-steroidal anti-rheumatic (NSAR) or an antidepressant.

Abstract: Rapidly disintegrating oral dosage forms for the application of active agent combinations for diabetes therapy. The dosage forms contain at least two active agents suitable for treating type-2 diabetes. The antidiabetic active agents are selected from the group comprising sulfonylureas, glitazones, glinides, biguanides, and absorption-delaying agents. The use of the active agent combination to produce an oral dosage form for the treatment of diabetes, a method for the therapeutic treatment of diabetes, and a method for the production of a sheet-like dosage form are also disclosed.

Abstract: A sheet-like pharmaceutical preparation (dosage form) that quickly disintegrates on contact with moisture, based on hydrophilic polymers for the release of at least one active agent. The dosage form contains an active agent combination for treating depression, and at least one active agent selected from the antidepressant group of drugs. In addition, the use of such a combination of active agents for the production of an orally administrable pharmaceutical product for the treatment of depression, and the therapeutic treatment of depression by oral administration of one of the named pharmaceutical preparations, is provided.

Abstract: Sheet-like pharmaceutical preparations based on hydrophilic polymers, which rapidly disintegrate upon contact with moisture and which are used to treat dementia-related illnesses The dosage form contains an active agent combination of at least two active agents which are suitable for the treatment of dementia (antidementia agents). The antidementia agents should be chosen from the group comprising acetyl cholinesterase inhibitors (AChE inhibitors) and NMDA antagonists (n-methyl-D-asparaginic acid antagonists). The use of such an active agent combination for producing an orally administrable pharmaceutical product for the treatment of dementia-related illnesses such as Alzheimer's disease, as well as a procedure for the symptomatic treatment of Alzheimer's disease by the oral administration of one of the above pharmaceutical products is also provided.

Abstract: A hydrophile gel system for cosmetic and/or skin care applications. The gel system comprises a detachable carrier film and a hydrogel which contains at least 15 percent by weight of karaya gum and whose water content is less than 5 percent by weight.

Abstract: The present invention relates to Transdermal Therapeutic Systems having a silicone adhesive layer, to Transdermal Therapeutic Systems providing specific plasma concentrations, to their manufacture and use.

Abstract: Medical skin patches for treating colds by releasing essential oils through evaporation comprising a backing layer permeable to gas and water vapour and a hydrophile and pressure-sensitive adhesive polymer matrix connected to the backing layer. The matrix contains at least one essential oil, at least one hydrophile polymer, at least one substance having an adsorbent effect or/and at least one substance having an emulsifying effect, and at least one pressure-sensitive adhesive polymer. The water content of the matrix is less than 5% by weight, or even less than 1% by weight.